News Biden plan would axe interchangeable status for biosimilars President Joe Biden’s budget proposal for fiscal 2025 includes a proposal that would allow pharmacy substitution of biosimilar drugs for the reference product, even if the
News Samsung seeks 'interchangeable' label for Humira biosimilar While there are already a number of biosimilars of AbbVie's big-selling Humira on the US market, so far, only one – Boehringer Ingelheim's
Partner Content Partner Content Four Key Reasons to Attend SMi's 2019 Biosimilars Conference Four Key Reasons to Attend SMi's 2019 Biosimilars
Partner Content Partner Content Michel Mikhail invites Biosimilar experts to attend SMi’s 10... Michel Mikhail invites Biosimilar experts to attend SMi
Partner Content Partner Content Save the date for SMi’s 10th Annual Biosimilars Conference 2... Save the date for SMi’s 10th Annual Biosimilars Conf
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.